Delayed access to lung cancer screening and treatment during the COVID-19 pandemic: Are we headed for a lung cancer pandemic?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed.

1. Impact of the COVID-19 pandemic on lung cancer diagnosis in northern Poland-addressing the COVID-19 debt.PloS one · 2024
   Article
2. ACE2: the node connecting the lung cancer and COVID-19.American journal of cancer research · 2024
   Review
3. Availability and accessibility of services to address financial toxicity described by Australian lung cancer patients and healthcare professionals.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
   Article
4. Contemporary Concise Review 2021: COVID-19 and other respiratory infections.Respirology (Carlton, Vic.) · 2022
   Review
5. Hospital-based multidisciplinary lung cancer care in Australia: a survey of the landscape in 2021.BMJ open respiratory research · 2022
   Article
6. Susceptibility of lung cancer patients to COVID-19: A review of the pandemic data from multiple nationalities.Thoracic cancer · 2021
   Review
7. A note on lung cancer in the COVID-19 era.Respirology (Carlton, Vic.) · 2021
   Article
8. Provision of essential bronchoscopy during COVID-19 pandemic.Respirology (Carlton, Vic.) · 2021
   Article
9. A Canadian Perspective on the Challenges for Delivery of Curative-Intent Therapy in Stage III Unresectable Non-Small Cell Lung Cancer.Current oncology (Toronto, Ont.) · 2021
   Article
10. Pattern of cancer patient referral and organisational model of an interventional pulmonology programme during the COVID-19 pandemic.ERJ open research · 2021
    Article

Corrections and comments

• Commented on by
  A note on lung cancer in the COVID-19 era.2021
• Commented on by
  Provision of essential bronchoscopy during COVID-19 pandemic.2021
• Commented on by
  Reply.2021
• Comment on
  COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.2020

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as